| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/05/2002 | US20020123468 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| 09/05/2002 | US20020123068 Water-soluble peptidic substrate for use in electrophoretic separation |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1235914A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 09/04/2002 | EP1068223B1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/04/2002 | EP0949902B1 Cosmetic preparation with a peptide addition |
| 09/04/2002 | EP0920447B1 Process of purification of cyclosporin |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0896615B1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/04/2002 | EP0832104B1 Dolastatin derivatives, their preparation and use |
| 09/04/2002 | EP0781141B1 Aza cyclohexapeptide compounds |
| 09/04/2002 | EP0771209B1 Novel peptides |
| 09/04/2002 | EP0590006B1 Synthetic pulmonary surfactant peptides |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367789A Synthesis of template-fixed beta-hairpin loop mimetics |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444787 Vaccines |
| 09/03/2002 | US6444786 Bactericides |
| 09/03/2002 | US6444645 Crosslink-stabilized indolicidin analogs |
| 09/03/2002 | US6444643 Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 09/03/2002 | CA2049089C Immunoassay reagents and method for determining cyclosporine |
| 08/29/2002 | WO2002066984A2 Arrays for determining binding of biomolecules |
| 08/29/2002 | WO2002066500A2 ANTAGONISTS FPR Α4β7-INTEGRIN |
| 08/29/2002 | WO2002066499A1 Cyclic peptide |
| 08/29/2002 | WO2002066498A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002065986A2 Transporters comprising spaced arginine moieties |
| 08/29/2002 | WO2002024235A3 Prochelators of radiometal labeled molecules |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002008256A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120107 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 08/29/2002 | US20020120101 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020119931 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119305 Controlled release composition |
| 08/29/2002 | US20020119165 Peptides for inhibition of herpes simplex virus entry |
| 08/29/2002 | US20020119096 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 08/29/2002 | DE10107707A1 Antagonisten für alpha¶4¶beta¶7¶-Integrin Antagonists of integrin alpha¶4¶beta¶7¶ |
| 08/29/2002 | CA2476397A1 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | CA2451089A1 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438415A1 Pixel arrays |
| 08/28/2002 | EP1233776A1 Urotensin-ii cyclic analogs |
| 08/28/2002 | EP1233774A1 Urotensin-ii analogs |
| 08/28/2002 | EP1084133B1 Redox reversible bipyridyl osmium complex conjugates |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/2002 | EP0828521B1 Sequestered imaging agents |
| 08/28/2002 | EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein |
| 08/28/2002 | EP0794961B1 Lhrh antagonist peptides |
| 08/28/2002 | CN1366539A Solid carrier based on linking agent for peptide and small molecular organic synthesis |
| 08/27/2002 | US6441141 Synthetic peptides, antibodies against them and their use |
| 08/27/2002 | US6441140 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/27/2002 | US6441132 Of given amino acid sequence (6-12 amino acids), including d-tryptophan residues; useful as anticonvulsant or neuroprotective agents |
| 08/27/2002 | US6441131 Peptides, method for assaying human pepsinogen II or human pepsin II, and assaying kit |
| 08/27/2002 | US6441130 Form triple stranded structures with nucleic acids |
| 08/27/2002 | US6440690 Peptides for the activation of the immune system in humans and animals |
| 08/27/2002 | US6440667 Analysis of target molecules using an encoding system |
| 08/27/2002 | US6440656 Methods for the inhibition of respiratory syncytial virus transmission |
| 08/27/2002 | CA1341386C Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method |
| 08/22/2002 | WO2002064734A2 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | WO2002064619A2 Peptides that inhibit poly-glutamine aggregation |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064091A2 Melanocortin metallopeptides for treatment of sexual dysfunction |
| 08/22/2002 | WO2002053583A3 Amphipathic peptides and their use for transferring substances of interest into cells |
| 08/22/2002 | WO2002037104A3 Method of purification of neuropeptide containing vesicles from the brain |
| 08/22/2002 | WO2002008250A3 Ghrelin antagonists |
| 08/22/2002 | WO2000023092A9 Contulakin-g, analogs thereof and uses therefor |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115824 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 08/22/2002 | US20020115823 Pentapeptide with specific conformation, its production and use |
| 08/22/2002 | US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders |
| 08/22/2002 | US20020115615 A peptide compound, where a residue of the peptide compound corresponding to the amino acid at position 6 of natural mammalian LHRH is replaced; anticarcinogenic and -tumor agents; hormone inhibitors; urogenital disorders |
| 08/22/2002 | US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries |
| 08/22/2002 | US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/22/2002 | US20020115133 Cyclic lipopeptide acylase |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |